AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16026400 — intervention group
Group type: COMPARATOR
Intervention: No thrombosis prophylaxis (Control)
Number of subjects: 42
Study 12423559 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola
Number of subjects: 24
Study 12423559 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 24
Study 12423559 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola + Acetazolamide
Number of subjects: 24
Study 12423559 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 24
Study 9467765 — intervention group
Group type: EXPERIMENTAL
Intervention: Handling $500 cash in a mock budgetary task
Number of subjects: 11
Study 9467765 — intervention group
Group type: COMPARATOR
Intervention: Imagining handling and budgeting the money (Control)
Number of subjects: 11
Study 8597522 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous m-CPP (0.08 mg/kg)
Number of subjects: 16
Study 8597522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2229859 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment process in acute hospital care (treatment group)
Number of subjects: 436
Study 2229859 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care (control group)
Number of subjects: 436
Study 344303 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 61
Study 344303 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 61
Study 29903799 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-friction (LF) bedding
Number of subjects: 221
Study 27627721 — intervention group
Group type: EXPERIMENTAL
Intervention: Endplate-conformed cage (C)
Number of subjects: 12
Study 27627721 — intervention group
Group type: COMPARATOR
Intervention: Non-conformed cage (N)
Number of subjects: 12
Study 27627721 — intervention group
Group type: COMPARATOR
Intervention: Intact group (I)
Number of subjects: 12
Study 27627721 — intervention group
Group type: EXPERIMENTAL
Intervention: Finite Element Model (C)
Number of subjects: 12
Study 26574751 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pressure, intermittent pneumatic compression (HPIPC) 60 minutes twice daily for 16 weeks
Number of subjects: 34
Study 26574751 — intervention group
Group type: COMPARATOR
Intervention: Standard care consisting of an exercise regimen of walking for 20 minutes twice daily for 16 weeks
Number of subjects: 34
Study 24404664 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% anerdian III
Number of subjects: 295
Study 27534056 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard antibiotic therapy and Wobenzym
Number of subjects: 90
Study 27534056 — intervention group
Group type: COMPARATOR
Intervention: Standard antibiotic therapy
Number of subjects: 90
Study 18308012 — intervention group
Group type: EXPERIMENTAL
Intervention: New-onset diabetes mellitus (DM)
Number of subjects: 1298
Study 18308012 — intervention group
Group type: EXPERIMENTAL
Intervention: New-onset diabetes mellitus (DM) with AF
Number of subjects: 1298
Study 18308012 — intervention group
Group type: COMPARATOR
Intervention: Patients without diabetes mellitus (DM)
Number of subjects: 1298
Study 15898381 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasted metal brackets (SB) bonded with resin-modified glass ionomer cement
Number of subjects: 60
Study 15898381 — intervention group
Group type: COMPARATOR
Intervention: Control group: Mesh-based (no sandblasting) brackets bonded with resin-modified glass ionomer cement (CO)
Number of subjects: 60
Study 12803576 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of extended-release aspirin (ERASA)
Number of subjects: 20
Study 12803576 — intervention group
Group type: COMPARATOR
Intervention: 150 mg of plain-formulated aspirin (PFASA)
Number of subjects: 20
Study 11004139 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic ventricular fibrillation (no-touch technique)
Number of subjects: 211
Study 11004139 — intervention group
Group type: EXPERIMENTAL
Intervention: Beating heart revascularization (no-pump technique)
Number of subjects: 211
Study 11004139 — intervention group
Group type: COMPARATOR
Intervention: Overall in-hospital mortality rate
Number of subjects: 211
Study 8927667 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 230
Study 1800302 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg once daily for first 2 weeks and 10 mg once daily for subsequent 2 weeks
Number of subjects: 49
Study 1800302 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine 10 mg tid for 4 weeks
Number of subjects: 49
Study 7055378 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 gms/day amino acids
Number of subjects: 29
Study 7055378 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 gms/day glucose
Number of subjects: 29
Study 7055378 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 gms/day glucose + 70 gms/day amino acids
Number of subjects: 29
Study 7055378 — intervention group
Group type: COMPARATOR
Intervention: 90 gms/day glucose (normal subjects)
Number of subjects: 29
Study 7055378 — intervention group
Group type: COMPARATOR
Intervention: 70 gms/day amino acids (normal subjects)
Number of subjects: 29
Study 7055378 — intervention group
Group type: COMPARATOR
Intervention: No caloric intake (normal subjects)
Number of subjects: 29
Study 31504399 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose rivaroxaban added to aspirin
Number of subjects: 27390
Study 31504399 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (control)
Number of subjects: 27390
Study 28134983 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 110
Study 28134983 — intervention group
Group type: COMPARATOR
Intervention: 2.5% NaOCl
Number of subjects: 110
Study 28406103 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote-online case-based learning (RO-CBL)
Number of subjects: 38
Study 28406103 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face case-based learning (control)
Number of subjects: 38
Study 28406103 — intervention group
Group type: COMPARATOR
Intervention: Control group (face-to-face CBL)
Number of subjects: 38
Study 28406103 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group responses
Number of subjects: 38
Study 25325911 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy in the fifth protocol (n=46)
Number of subjects: 656
Study 25325911 — intervention group
Group type: COMPARATOR
Intervention: Endovascular therapy in the first 4 protocols (n=610)
Number of subjects: 656
Study 22580220 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion acceptance
Number of subjects: 94
Study 22580220 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion suppression
Number of subjects: 94
Study 22580220 — intervention group
Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 94
Study 19525084 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention to improve hypertension control
Number of subjects: 0
Study 18597599 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride/stannous fluoride (ASF) mouthrinse at 10 ml (ASF-10)
Number of subjects: 15
Study 18597599 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride/stannous fluoride (ASF) mouthrinse at 20 ml (ASF-20)
Number of subjects: 15
Study 18597599 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oils (EO) mouthrinse
Number of subjects: 15
Study 18597599 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHX) rinse
Number of subjects: 15
Study 18597599 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 15
Study 16267959 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (30 mg/kg over three days, 10 mg/kg/day)
Number of subjects: 119
Study 16267959 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (30 mg/kg over three days, 10 mg/kg/day)
Number of subjects: 119
Study 12427293 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study 12427293 — intervention group
Group type: COMPARATOR
Intervention: Medication-free trial after SSRI treatment
Number of subjects: 0
Study 12427293 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of SSRI treatment
Number of subjects: 0
Study 11916786 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 2 microg/kg
Number of subjects: 60
Study 11916786 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 4 microg/kg
Number of subjects: 60
Study 11916786 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 60
Study 11916786 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 9457946 — intervention group
Group type: EXPERIMENTAL
Intervention: Swim-up technique
Number of subjects: 363
Study 9457946 — intervention group
Group type: EXPERIMENTAL
Intervention: Percoll gradient centrifugation technique
Number of subjects: 363
Study 9457946 — intervention group
Group type: COMPARATOR
Intervention: Natural cycles
Number of subjects: 363
Study 9457946 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate-stimulated cycles
Number of subjects: 363
Study 9457946 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-stimulated cycles
Number of subjects: 363
Study 9457946 — intervention group
Group type: COMPARATOR
Intervention: Washing, swim-down, refrigeration/heparin techniques
Number of subjects: 363
Study 7699828 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Sedation (PCS) - 1.0 mg bolus dose of midazolam
Number of subjects: 100
Study 7699828 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Sedation (PCS) - 1.5 mg bolus dose of midazolam
Number of subjects: 100
Study 7699828 — intervention group
Group type: COMPARATOR
Intervention: Anesthesiologist-Controlled Sedation (ACS) - 1.5 mg bolus dose of midazolam
Number of subjects: 100
Study 2624937 — intervention group
Group type: EXPERIMENTAL
Intervention: SSR IUD
Number of subjects: 710
Study 2624937 — intervention group
Group type: EXPERIMENTAL
Intervention: MLCu250 IUD
Number of subjects: 710
Study 2624937 — intervention group
Group type: EXPERIMENTAL
Intervention: UCD IUD
Number of subjects: 710
Study 2624937 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu 220C IUD
Number of subjects: 710
Study 91251 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin (ADM) alone
Number of subjects: 15
Study 91251 — intervention group
Group type: COMPARATOR
Intervention: Bleomycin (BLM) alone
Number of subjects: 15
Study 91251 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin (ADM) combined with local hyperthermia (42-43 degrees C)
Number of subjects: 15
Study 91251 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin (BLM) combined with local hyperthermia (42-43 degrees C)
Number of subjects: 15
Study 91251 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin (ADM) combined with local hyperthermia (42-43 degrees C) at 4-month follow-up
Number of subjects: 15
Study 91251 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin (BLM) combined with local hyperthermia (42-43 degrees C) at 4-month follow-up
Number of subjects: 15
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime prevalence of at least one mood, anxiety or alcohol use disorder
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depressive disorder (MDD)
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol abuse
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: Any DSM-IV mental disorders (12-month prevalence)
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: Obsessive compulsive disorder (OCD)
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime prevalence of mental disorders in SMHS 2016
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month prevalence of mental disorders in SMHS 2016
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime GAD
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month prevalence of GAD
Number of subjects: 6126
Study 30947763 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month prevalence of OCD
Number of subjects: 6126
Study 27891622 — intervention group
Group type: EXPERIMENTAL
Intervention: afoxolaner/milbemycin oxime chews (1×)
Number of subjects: 32
Study 27891622 — intervention group
Group type: EXPERIMENTAL
Intervention: afoxolaner/milbemycin oxime chews (3×)
Number of subjects: 32
Study 27891622 — intervention group
Group type: EXPERIMENTAL
Intervention: afoxolaner/milbemycin oxime chews (5×)
Number of subjects: 32
Study 27891622 — intervention group
Group type: COMPARATOR
Intervention: untreated, sham-dosed control
Number of subjects: 32
Study 25347141 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrument-assisted soft tissue mobilization (ISTM)
Number of subjects: 11
Study 25347141 — intervention group
Group type: COMPARATOR
Intervention: Control leg (CL)
Number of subjects: 11
Study 23475568 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (IR and XR formulations)
Number of subjects: 305
Study 21094018 — intervention group
Group type: EXPERIMENTAL
Intervention: CNA IPT scores
Number of subjects: 326
Study 21094018 — intervention group
Group type: EXPERIMENTAL
Intervention: CNA IPT, CSDD, PAS, education
Number of subjects: 326
Study 21094018 — intervention group
Group type: EXPERIMENTAL
Intervention: MDS pain frequency, CSDD, CNA IPT, CNPI, age
Number of subjects: 326
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum albumin
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum magnesium (Mg)
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ferritin
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cholesterol
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of folate and fiber
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of iron, thiamin, riboflavin
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of omega‐3 fatty acids
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar intake
Number of subjects: 38
Study 19142564 — intervention group
Group type: EXPERIMENTAL
Intervention: Food avoidance
Number of subjects: 38
Study 17275226 — intervention group
Group type: EXPERIMENTAL
Intervention: Black cohosh (160 mg daily)
Number of subjects: 351
Study 17275226 — intervention group
Group type: EXPERIMENTAL
Intervention: Multibotanical including black cohosh (200 mg daily)
Number of subjects: 351
Study 17275226 — intervention group
Group type: EXPERIMENTAL
Intervention: Multibotanical plus soy diet counseling
Number of subjects: 351
Study 17275226 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen .625 mg, with or without medroxyprogesterone acetate 2.5mg daily
Number of subjects: 351
Study 17275226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 15491248 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 254
Study 15491248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 11681821 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins with iron (MV with iron) administered daily for 3 months
Number of subjects: 310
Study 11681821 — intervention group
Group type: COMPARATOR
Intervention: Noniron multivitamins (MV without iron) administered daily for 3 months
Number of subjects: 310
Study 9226158 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (filgrastim) 5 microg/kg/d subcutaneously
Number of subjects: 53
Study 9226158 — intervention group
Group type: COMPARATOR
Intervention: Control (no growth factor)
Number of subjects: 53
Study 7957490 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg sublingual nitroglycerin (NTG)
Number of subjects: 22
Study 7957490 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 22
Study 3686222 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemonucleolysis
Number of subjects: 20
Study 3686222 — intervention group
Group type: COMPARATOR
Intervention: Control (Diagnostic discography without enzyme injection)
Number of subjects: 20
Study 28930874 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of fish oil daily for 21 days
Number of subjects: 22
Study 28930874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 27788053 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/d of cholecalciferol
Number of subjects: 829
Study 27788053 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 829
Study 24787495 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose supplementation (2 g/kg body weight)
Number of subjects: 22
Study 24787495 — intervention group
Group type: COMPARATOR
Intervention: Artificial sweeteners supplementation
Number of subjects: 22
Study 22250190 — intervention group
Group type: EXPERIMENTAL
Intervention: 500‐mL pump dispenser
Number of subjects: 87
Study 22250190 — intervention group
Group type: EXPERIMENTAL
Intervention: 125‐mL squeeze bottle dispenser
Number of subjects: 87
Study 22250190 — intervention group
Group type: COMPARATOR
Intervention: 50‐mL roll‐on dispenser
Number of subjects: 87
Study 19879555 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application
Number of subjects: 97
Study 19879555 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 97
Study 18519523 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 421
Study 18519523 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 421
Study 18519523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study 16061828 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine suppressive treatment
Number of subjects: 22
Study 16061828 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine withdrawal
Number of subjects: 22
Study 16061828 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 euthyroid individuals)
Number of subjects: 22
Study 14692208 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total Advanced Fresh toothpaste
Number of subjects: 32
Study 14692208 — intervention group
Group type: COMPARATOR
Intervention: Commercial fluoridated breath-freshening dentifrice
Number of subjects: 32
Study 10879311 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-antibiotic ointment (polymyxin B-bacitracin-neomycin), applied twice daily for up to 14 days
Number of subjects: 70
Study 10879311 — intervention group
Group type: COMPARATOR
Intervention: Simple gauze-type dressing, applied twice daily for up to 14 days
Number of subjects: 70
Study 8636300 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (100 mg, im, weekly) plus levonorgestrel (500 micrograms, orally, daily)
Number of subjects: 36
Study 8636300 — intervention group
Group type: COMPARATOR
Intervention: Testosterone enanthate (100 mg, im, weekly) alone
Number of subjects: 36
Study 8636300 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate plus levonorgestrel
Number of subjects: 36
Study 8636300 — intervention group
Group type: COMPARATOR
Intervention: Testosterone enanthate alone
Number of subjects: 36
Study 1466089 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei preparation (BLP), 3 g/day
Number of subjects: 58
Study 1466089 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 6141114 — intervention group
Group type: EXPERIMENTAL
Intervention: Loprazolam (1 mg)
Number of subjects: 197
Study 6141114 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (20 mg)
Number of subjects: 197
Study 6141114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 3553244 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestalt empty chair dialogues designed to be personally relevant and high in affect
Number of subjects: 44
Study 3553244 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialogues designed to be personally irrelevant and neutral in affect
Number of subjects: 44
Study 3553244 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups in which strong affect was encouraged, but no dialogues enacted
Number of subjects: 44
Study 3553244 — intervention group
Group type: COMPARATOR
Intervention: Attention-placebo
Number of subjects: 44
Study 29872280 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based self-care program alone (HB group, n=275)
Number of subjects: 12054
Study 29872280 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based program + weekly class-style session (CS group, n=251)
Number of subjects: 12054
Study 29872280 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonintervention regions, n=7,195)
Number of subjects: 12054
Study 27743205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration of paliperidone palmitate (3-month formulation)
Number of subjects: 651
Study 26395620 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS (cathode over left and anode over right parietal region) during neurorehabilitation
Number of subjects: 30
Study 26395620 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS during neurorehabilitation
Number of subjects: 30
Study 23639481 — intervention group
Group type: EXPERIMENTAL
Intervention: Depo-Provera (depo-MPA)
Number of subjects: 51
Study 23639481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCP)
Number of subjects: 51
Study 23639481 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 51
Study 21178594 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg intravenous infusion)
Number of subjects: 15
Study 21178594 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo control)
Number of subjects: 15
Study 18450870 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation plus oral rehydration salts
Number of subjects: 180000
Study 18450870 — intervention group
Group type: COMPARATOR
Intervention: Oral rehydration salts alone (Control)
Number of subjects: 180000
Study 16504531 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump CABG (CPB)
Number of subjects: 30